VVOS - Vivos Therapeutics EPS misses by $0.93 beats on revenue March, 25 2021 04:54 PM Vivos Therapeutics Inc. Vivos Therapeutics (VVOS): FY GAAP EPS of -$1.40 misses by $0.93.Revenue of $13.07M (+14.7% Y/Y) beats by $0.13M.Shares +3.22%.Press Release For further details see: Vivos Therapeutics EPS misses by $0.93, beats on revenue